✦ LIBER ✦

Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin 40 mg Daily (from the ASTEROID Study)

✍ Scribed by Stephen D. Wiviott; Satishkumar Mohanavelu; Joel S. Raichlen; Valerie A. Cain; Steven E. Nissen; Peter Libby

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety Profile of Subjects Treated to Ve

✍ Everett, Brendan M. (author);Mora, Samia (author);Glynn, Robert J. (author);Macf 📂 Article 📅 2014 🏛 Elsevier Inc. 🌐 English ⚖ 585 KB

Safety Profile of Subjects Treated to Ve

✍ Everett, Brendan M. (author);Mora, Samia (author);Glynn, Robert J. (author);Macf 📂 Article 📅 2014 🏛 Elsevier Inc. 🌐 English ⚖ 585 KB

Can Low-Density Lipoprotein Be Too Low?

✍ Stephen D. Wiviott; Christopher P. Cannon; David A. Morrow; Kausik K. Ray; Marc 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Effect of Central Obesity, Low High-Dens

✍ Miao Hu; Michael H.K. Lee; Valiant W.L. Mak; Brian Tomlinson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Safety and Efficacy of Atorvastatin-Indu

✍ John C. LaRosa; Scott M. Grundy; John J.P. Kastelein; John B. Kostis; Heiner Gre 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Comparison of Effectiveness of Rosuvasta

✍ D. John Betteridge; J. Martin Gibson; Philip T. Sager 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB